Portfolio company
Freedom Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops ketamine and psychedelic therapeutics for patients suffering from treatment-resistant depression and other mental health conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Freedom
This biotechnology company develops ketamine and psychedelic combination therapies to treat patients with mental health conditions and substance use disorders.
Bexson Biomedical
This biopharmaceutical company develops subcutaneous ketamine delivery technologies and wearable devices to treat patients with chronic pain and mental health conditions.
Beckley Psytech
The company develops psychedelic-derived medicines to treat patients with neurological and psychiatric conditions such as treatment-resistant depression and rare headache disorders.
GH Research
This pharmaceutical company develops psychedelic-based therapies for patients suffering from psychiatric and neurological disorders, including treatment-resistant depression.
Journey Clinical
This company provides a platform and medical infrastructure enabling psychotherapists to deliver ketamine-assisted psychotherapy to patients with mental health conditions.
Reunion Neuroscience
This biopharmaceutical company develops psychedelic-inspired therapeutic solutions for patients with underserved mental health disorders, such as postpartum depression and anxiety.
Compass Pathways
This biotechnology company develops psilocybin-based therapies for patients living with treatment-resistant depression and other mental health conditions.
Mindstate Design Labs
This biotechnology company develops custom psychedelic therapeutics using an artificial intelligence platform to treat mental health conditions for patients with various psychiatric disorders.
